Register Now - Beyond Recruitment: The Future of Patient Site Engagement in Oncology Clinical Trials
|Articles|August 27, 2008

Biomedical Systems Announces Vice President, Imaging Services

Biomedical Systems, a global provider of centralized diagnostic testing for the pharmaceutical and medical device industry, recently announced the promotion of Sam Dranoff to Vice Present of Business Development, Imaging Services.

Biomedical Systems Announces Vice President, Imaging Services

August 27, 2008 – St. Louis, MO – Biomedical Systems, a global leader in centralized diagnostic testing for the pharmaceutical and medical device industry, recently announced the promotion of Sam Dranoff to Vice Present of Business Development, Imaging Services.  Dranoff will continue with his current responsibilities while growing a team of global business development directors for Biomedical Systems, Imaging Services.  The business unit has experienced significant growth since Dranoff joined the division in 2005, and most recently served as Managing Director, Commercial Operations.

"We have grown the imaging business to a point where we see a need for expanding the Business Development team.  Sam has the proven experience and talent to grow and manage this team as well as the vision to see it succeed.  That is why I'm so excited that he has accepted this new position and I'm confident that he will add great value in his new role." said Jesse Bowden, President of Imaging Services, Biomedical Systems.

Biomedical Systems is a fully digital imaging core lab that supports clinical trials in dozens of therapeutic categories.  Leveraging combined corporate resources that includes ECG core lab and respiratory core lab, Biomedical Imaging Services provides sponsors unmatched diagnostic service offerings on a global basis.

Biomedical Systems is a global provider of centralized diagnostic services for the pharmaceutical and medical device industries. With offices in North America, Europe and Asia, Biomedical Systems has worked with over 11,000 investigative sites in 75 countries around the world for Phase I - IV clinical trials. Biomedical Systems centralized services include the acquisition, analysis and management of data for Cardiac, Imaging and Respiratory modalities used to determine safety and efficacy for drugs and devices in clinical trials. For more information about Biomedical Systems, please contact Traci Cardenas, Marketing Manager at 1-800-877-6334 (3338) or via email, tcardenas@biomedsys.com. Additional information can be found on the company website at www.biomedsys.com.


Related to this article

Closing the Community Access Gap: Q&A with Kent Thoelke, Paradigm Health
In this Q&A, Kent Thoelke, CEO of Paradigm Health, discusses why participation gaps in community and rural settings come down to both patient cost barriers and site infrastructure, how legacy workflows weigh on community clinics, and what policy and technology changes it would take to make clinical research a real care option for more patients.
© Grispb - © Grispb - stock.adobe.com
Mistral and OpenAI produced identical overall eligibility labels across 200 synthetic patient-study assessments, with criterion-level disagreements concentrated in inclusion criteria where models switch between “Uncertain” and “Not included” when records lack sufficient evidence, so model choice should be driven by deployment architecture, control, and cost rather than assumed interchangeability.
The Human Side of Clinical Trials: Before Burden Becomes Risk, Capturing Friction in Real Time
In Episode 4 of The Human Side of Clinical Trials, host Brian S. McGowan, PhD, FACEHP, chief learning officer and co-founder of ArcheMedX, Inc., speaks with Jason Riis, PhD, CEO and chief behavioral scientist at Behavioralize, about how capturing friction closer to the moment it happens can reveal unclear instructions, technology friction, and workarounds that retrospective surveys and debriefs tend to miss.